The prospective, double-blind, randomized controlled trial (RCT) enrolled 244 patients to evaluate the Butterfly Prostatic Retraction Device, a minimally invasive, reversible implant that mechanically ...
Butterfly Medical announced that it completed the final 12-month follow-up for all patients in a study of its prostatic ...
UCHealth hospital uses BPH AI to guide aquablation, improving precision and preserving sexual function in prostate treatment.
CHAD Thompson grappled with a silent problem for 20 years – he couldn’t pee properly, and it was a constant source of anxiety ...
Closes $36 Million Registered Direct Offering. This article has been disseminated on behalf of Profound Medical Corp. and may include paid advertising. Profound Medical Corp. (NASDAQ: PROF; TSX: PRN) ...
Research supports that both finasteride and dutasteride help treat hair loss, particularly when caused by androgenetic ...
A UK-led international clinical trial is recruiting 280 patients to see if the technique to remove cancerous cells could ...
Researchers identify APOC1 and NOP16 as promising prostate cancer biomarkers that could aid early diagnosis. Learn more about ...
DEAR DR. ROACH: I have benign prostatic hyperplasia (BPH), and I am taking tamsulosin daily. It works and helps with my daily urination. How long should I continue to take it? Are there any related ...
SOUTH SAN FRANCISCO, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Zenflow, Inc. announced today the U.S. Food and Drug Administration (FDA) approval of the Zenflow Spring ® Implant and Delivery System ...
Innovative Design Allows for Only Tailored BPH Approach that Preserves Natural Anatomy SOUTH SAN FRANCISCO, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Zenflow, Inc. announced today the U.S. Food and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback